您的位置: 首页 > 农业专利 > 详情页

METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS
专利权人:
Gosudarstvennoe byudzhetnoe uchrezhdenie zdravookhraneniya "Kraevaya klinicheskaya bolnitsa N2" Ministerstva zdravookhraneniya Krasnodarskogo kraya
发明人:
Durleshter Vladimir Moiseevich (RU),Дурлештер Владимир Моисеевич (RU),Katanyan Gevork Artushovich (RU),Катанян Геворк Артушович (RU),Titov Sergej Evgenevich (RU),Титов Сергей Евгеньевич (RU)
申请号:
RU2019110794
公开号:
RU0002705110C1
申请日:
2019.04.10
申请国别(地区):
RU
年份:
2019
代理人:
摘要:
FIELD: medicine.SUBSTANCE: invention refers to medicine, namely to endocrine surgery, and can be used for differential diagnosis of thyroid neoplasms. Thyroid ultrasonography is performed, nodal thyroid formations are detected. Puncture biopsy is performed, followed by cystic cytological examination. If the cytological indications are not clear, a molecular-genetic examination is performed, wherein the pre-dried cytological preparation is washed with 200 mcl lysis buffer from the cytological glasses. Further, DNA and microRNA are recovered from cytological preparations of a fine-needle aspiration puncture biopsy of thyroid neoplasms using assay kits. Detection and quantitative assessment of the diagnostically significant microRNAs is carried out based on the polymerase chain reaction method with fluorescent recording of the analysis result in real time using the CFX96(Bio-Rad Laboratories, USA) thermal cycler. If the HMGA2 values are more than 0.09, microRNA 221 is more than 0.0105 and microRNA 375 more than -12.1213, a follicular tumor with signs of malignancy is determined. If the microRNA-146b values are more than 0.1721, the papillary cancer is determined. If the siRNA-375 values are more than 5.2514, the medullary cancer is determined. Ratio of mitochondrial DNA / nuclear DNA ratio more than 5716.3013 defines B-cell cancer. Presence of the V600 mutation in the BRAF gene determines a papillary cancer and is a risk of high biological aggressiveness of the given papillary cancer and a common process.EFFECT: method provides reducing the number of unreasonable surgical interventions that can lead to a significant decrease in the quality of life by having specific postoperative complications (laryngeal paresis of about 4–6 % in specialized institutions, up to 20 % in general surgical institutions, postoperative hypoparathyroidism 4–30 %, which can lead to persistent irreversible changes of bone tissue) due to higher reliability of thyroid tumor verification by molecu
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充